Oxalate formation from ascorbic acid
Oxalate formation from ascorbic acid
批准号:
10583560
负责人:
John Knight
金额:
$62.31万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-04-01 至 2025-02-28
关键词:
AccelerationAdultAffectAnimal ExperimentsAnimal ModelAntioxidantsAscorbic AcidAttenuatedBiological ModelsCalciumCalcium OxalateCarbonCell LineCell modelChromatographyConsumptionCoupledCultured CellsCysteineDetectionDietDietary intakeDiseaseDoseExcretory functionFemaleFoodGenerationsGlutathioneGuloHealth Care CostsHumanHuman VolunteersIngestionIntakeIntravenousInvestigationIonsKidneyKidney CalculiKnockout MiceLabelMeasurementMeasuresMetabolicMetabolismMitochondriaModelingMusNutrientNutritional StudyObesityOralOrganellesOxalatesOxidantsOxidative StressPlasmaPopulationProcessProductionQuality of lifeReactive Oxygen SpeciesRecommended Daily AllowancesResearchRiskRisk FactorsRoleSamplingSmall Interfering RNASourceTechniquesTestingThinnessUrineabsorptiondefined contributiondietarydietary controlepidemiology studyexperimental studyhuman subjectmalemouse modelneutrophilobese personscreeningstable isotopeuptakeurinary
中文摘要
项目总结:
草酸钙和结石病的发病率占美国总人口的近10%,这对糖尿病有很大影响。
医疗保健成本高,对生活质量有负面影响。尿液中草酸的排泄量是一个已知的风险。
导致结石的因素是草酸钙。大约50%的尿草酸钙来源于日常饮食习惯和饮食习惯。
抗坏血酸是一种非常重要的抗氧化剂,在体内的代谢过程中,它是一种重要的抗氧化剂。
尿液中草酸的来源来自内源性脂肪合成。然而,这一来源的主要贡献率与健康有关。
尿中草酸的排泄量还没有很好的定义。之前的实验一直受到以下因素的阻碍:缺乏对尿草酸的控制。
饮食中的草酸导致尿液中的草酸和排泄物中的草酸,以及(2)非营养性疾病中令人困惑的第二代草酸。
酸化后的尿液样品。每一天AAA的平均周转率约为8000万毫克,这可能是可行的结果。
每天形成高达40毫克的草酸。我们还测量了草酸营业额对尿液的贡献率。
在为数不多的正常成年人中,草酸盐的排泄与被标记为AAA的口服药物剂量有关。
经证实,尿液中内源性草酸约占40%-50%。这些都是初步调查结果。
研究结果表明,AA的周转率是尿液中草酸的主要来源,而尿中草酸来自内源性蛋白质的合成。
我们还将评估在成人非石材成型和CaOx石材成型过程中,草酸根向草酸根的转化率。
成年人正在使用最稳定的碳-13氨基酸,我们还将进一步研究肥胖对健康的影响,这是一种新的研究方法。
据了解,这可能与系统性氧化应激有关,并导致血浆AAA浓度下降。
转换也会增加草酸盐的排泄。在营养研究中发现的受试者将摄入已知数量的草酸。
饮食中的食源性维生素A也被控制在草酸、钙和其他营养成分的含量上。
我们将在培养的小鼠骨髓细胞和小鼠胚胎模型中进行研究,以便系统地研究人类再生障碍性贫血之间的关系。
草酸是在这一过程中起主要作用的抗氧化剂,也是线粒体和氨基酸在这一过程中的主要作用。
细胞器、细胞和组织将确定抗氧化剂是否可以钝化来自AAA的草酸盐形成。如果这些研究是正确的。
他们表示,成功的研究将为减少尿中草酸排泄和肾结石开辟新的研究途径。
队形。
英文摘要
Project Summary
Calcium oxalate stone disease occurs in nearly 10% of the U.S. population and contributes significantly to
health care costs and negatively impacts quality of life. The amount of oxalate excreted in urine is a known risk
factor for calcium oxalate stone disease. Approximately 50% of urinary oxalate is derived from the diet and the
remaining from endogenous synthesis. The metabolism of ascorbic acid (AA), an important antioxidant, is a
source of urinary oxalate derived from endogenous synthesis. However, the contribution of this source to
urinary oxalate excretion is not well defined. Prior experiments have been hampered by 1) a lack of control of
dietary oxalate to urinary oxalate excretion and 2) the confounding generation of oxalate from AA in non-
acidified urine samples. The turnover of AA each day is approximately 80 mg and could feasibly result in the
formation of up to 40 mg of oxalate per day. We have measured the contribution of AA turnover to urinary
oxalate excretion with carbon-13 labelled AA oral dosing in a small number of normal adults and have
confirmed that AA contributes 40 -50 % of the endogenous oxalate excreted in urine. These preliminary
findings suggest AA turnover is a major source of urinary oxalate derived from endogenous synthesis. In this
proposal we will assess the conversion of AA to oxalate in non-stone forming adults and CaOx stone forming
adults using the stable isotope of AA, carbon-13 AA. We will further examine the effects of obesity, which is
known to be associated with systemic oxidative stress and a decreased plasma AA concentration, on this
conversion as well as increased oxalate excretion. Subjects in nutritional studies will ingest known amounts of
food-derived AA in diets also controlled in their contents of oxalate, calcium and other nutrients. Experiments
will be conducted in cultured cells and mouse models to systematically examine the relationships between AA
and oxalate, the role of pro-oxidants in this process, the role of mitochondria and AA transport into this
organelle, and to determine whether antioxidants can blunt oxalate formation from AA. If these studies are
successful they will open new avenues of research for decreasing urinary oxalate excretion and kidney stone
formation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Oxalate formation from ascorbic acid
-
批准号:10094963
-
项目类别:
-
资助金额:$62.31万
-
财政年份:2021
-
负责人:John Knight
-
依托单位:
Oxalate formation from ascorbic acid
-
批准号:10374713
-
项目类别:
-
资助金额:$62.31万
-
财政年份:2021
-
负责人:John Knight
-
依托单位:
Oxalobacter formigenes colonization and oxalate excretion in calcium oxalate kidney stone disease
-
批准号:9896806
-
项目类别:
-
资助金额:$44.21万
-
财政年份:2017
-
负责人:John Knight
-
依托单位:
Oxalobacter formigenes colonization and oxalate excretion in calcium oxalate kidney stone disease
-
批准号:9240267
-
项目类别:
-
资助金额:$44.21万
-
财政年份:2017
-
负责人:John Knight
-
依托单位:
Oxalate handling and Oxalobacter formigenes colonization in a mouse model
-
批准号:8212289
-
项目类别:
-
资助金额:$32.19万
-
财政年份:2011
-
负责人:John Knight
-
依托单位:
Oxalate handling and Oxalobacter formigenes colonization in a mouse model
-
批准号:8802873
-
项目类别:
-
资助金额:$31.97万
-
财政年份:2011
-
负责人:John Knight
-
依托单位:
Oxalate handling and Oxalobacter formigenes colonization in a mouse model
-
批准号:8585762
-
项目类别:
-
资助金额:$38.28万
-
财政年份:2011
-
负责人:John Knight
-
依托单位:
Oxalate handling and Oxalobacter formigenes colonization in a mouse model
-
批准号:8042403
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2011
-
负责人:John Knight
-
依托单位:
海外基金